CompaniesBiowest Therapeutics

Biowest Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

1,943

By Phase

PHASE2: 6PHASE3: 1

By Status

COMPLETED: 6UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
Today
NCT00027248
NCT00292084
NCT00332176
Hover over trial bars to see details

Recent Trials

NCT00332176Lead Sponsor
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
PHASE2Unknown
50 participants
Started: Jun 30, 2006 · Completed: Dec 31, 2008
NCT00292084Lead Sponsor
An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
PHASE2Completed
60 participants
Started: Feb 28, 2006 · Completed: Oct 31, 2007
NCT00217139Lead Sponsor
A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
PHASE2Completed
60 participants
Started: Sep 30, 2005 · Completed: Sep 30, 2006
NCT00157534Lead Sponsor
A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection
PHASE2Completed
43 participants
Started: Oct 31, 2004 · Completed: Aug 31, 2005
NCT00211497Lead Sponsor
Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
PHASE2Completed
255 participants
Started: Jan 31, 2003 · Completed: Sep 30, 2003
View all 7 trials →